Free shipping on all orders over $ 500

Bevenopran

Cat. No. M21657

All AbMole products are for research use only, cannot be used for human consumption.

Bevenopran Structure
Synonym:

CB-5945; ADL-5945

Size Price Availability
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Bevenopran (CB-5945) is a peripheral μ-opioid receptor antagonist. Bevenopran tends to increase bowel movement (BM) frequency, especially for 0.1 mg twice daily and 4 mg daily, respectively.

Chemical Information
Molecular Weight 386.44
Formula C20H26N4O4
CAS Number 676500-67-7
Solubility (25°C) DMSO ≥ 90 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Jasper Pannemans, et al. United European Gastroenterol J. New developments in the treatment of opioid-induced gastrointestinal symptoms

Related Opioid Receptor Products
Tegileridine

Tegileridine is the potent agonist of opioid receptor (MOR). Tegileridine is an oxa spiro derivative which reduces the side effects mediated by β-arrestin.

Morphiceptin

Morphiceptin is a potent and specific agonist for morphine (μ) receptors.

[Met5]-Enkephalin, amide TFA

[Met5]-Enkephalin, amide TFA is an agonist for δ opioid receptors as well as putative ζ (zeta) opioid receptors.

DPDPE

DPDPE, an opioid peptide, is a selective δ-opioid receptor (DOR) agonist with anticonvulsant effects.

Gluten Exorphin C

Gluten exorphin C is an opioid peptide derived from wheat gluten.

  Catalog
Abmole Inhibitor Catalog




Keywords: Bevenopran, CB-5945; ADL-5945 supplier, Opioid Receptor, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.